The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study (Q34809526)

4 August 2017

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study (English)

1 reference

multicenter clinical trial

4 August 2017

0 references

author

Joanna Chorostowska-Wynimko

3

Joanna Chorostowska-Wynimko

1 reference

4 August 2017

Tomasz Powrózek

4

0 references

Kamila Wojas-Krawczyk

Kamila Wojas-Krawczyk

12

0 references

Dariusz M Kowalski

Dariusz M Kowalski

23

0 references

Wojciech Jóźwicki

Wojciech Jóźwicki

20

0 references

Paweł Krawczyk

Paweł Krawczyk

1

0 references

Maciej Krzakowski

Maciej Krzakowski

24

0 references

Rodryg Ramlau

Rodryg Ramlau

2

0 references

Janusz Limon

6

Janusz Limon

1 reference

4 August 2017

25

Jacek Jassem

1 reference

4 August 2017

14

Rafał Dziadziuszko

1 reference

4 August 2017

10

Ewa Kalinka-Warzocha

1 reference

4 August 2017

7

Bartosz Wasąg

1 reference

4 August 2017

21

Wojciech Dyszkiewicz

1 reference

4 August 2017

11

Aleksandra Szczęsna

1 reference

4 August 2017

26

Janusz Milanowski

1 reference

4 August 2017

18

Bożena Jarosz

1 reference

4 August 2017

9

Jerzy Kozielski

1 reference

4 August 2017

19

Aldona Woźniak

1 reference

4 August 2017

13

Michał Skroński

1 reference

4 August 2017

17

Justyna Szumiło

1 reference

4 August 2017

Marzena Anna Lewandowska

5

1 reference

4 August 2017

Juliusz Pankowski

8

1 reference

4 August 2017

Paulina Jaguś

15

1 reference

4 August 2017

Ewelina Antoszewska

16

1 reference

4 August 2017

Monika Pasieka-Lis

22

1 reference

4 August 2017

3 August 2014

1 reference

Journal of Cancer Research and Clinical Oncology

4 August 2017

1 reference

4 August 2017

141

1 reference

4 August 2017

1

1 reference

4 August 2017

61-68

1 reference

Creative Commons Attribution 4.0 International

4 August 2017

start time

3 August 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00432-014-1789-x

0 references

cites work

EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

EGFR gene mutation study in cytology specimens

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Molecular pathology of non-small cell lung cancer: a practical guide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Screening for epidermal growth factor receptor mutations in lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4282872

EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.

8 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1789-X

Epidermal growth factor receptor gene analysis with a highly sensitive molecular assay in routine cytologic specimens of lung adenocarcinoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25086987

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00432-014-1789-X

1 reference

4 August 2017

1 reference

4 August 2017

1 reference